Involvement and Clinical Aspects of MicroRNA in Osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Osteosarcoma (OS) is the most common primary bone cancer in children and adolescents.
• Its pathogenesis is complex due to heterogeneous genetic and cytogenetic abnormalities, including tumor suppressor mutations and oncogene activation.
• Genetic instability, DNA amplifications, and deletions are implicated in OS tumorigenesis.

Purpose of the Study:

• To review the current knowledge on the clinical applications of microRNAs (miRNAs) in osteosarcoma.
• To highlight the role of miRNAs in the diagnosis and management of OS.
• To explore how miRNA dysregulation contributes to cancer development.

Main Methods:

• Literature review of studies on microRNAs and osteosarcoma.
• Analysis of research on miRNA expression patterns in OS.
• Examination of the diagnostic and therapeutic potential of miRNAs in OS.

Main Results:

• MicroRNAs (miRNAs) are critical noncoding RNAs regulating cell differentiation, growth, and death.
• Dysregulation of miRNA expression is linked to phenotypic and genotypic changes driving cancer development.
• miRNAs have demonstrated significant potential in cancer diagnosis and treatment strategies.

Conclusions:

• miRNAs represent a promising avenue for the improved diagnosis of osteosarcoma.
• Clinical applications of miRNAs can enhance the management and treatment strategies for OS patients.
• Further research into miRNA biomarkers may lead to novel therapeutic interventions for osteosarcoma.